#Telix_Pharmaceuticals
Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements#USA#San_Francisco#Prostate_Cancer#Telix_Pharmaceuticals#TLX
Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements
Hagens Berman warns Telix Pharmaceuticals investors of an impending class action due to alleged misrepresentations regarding prostate cancer treatments and supply chains.
third-news.com
January 8, 2026 at 6:09 PM
Investors of Telix Pharmaceuticals Limited Have Chance to Join Securities Fraud Class Action#USA#Los_Angeles#Securities_Fraud#Telix_Pharmaceuticals#TLX
Investors of Telix Pharmaceuticals Limited Have Chance to Join Securities Fraud Class Action
Shareholders of Telix Pharmaceuticals Limited who incurred losses can take part in a securities fraud class action lawsuit led by The Law Offices of Frank R. Cruz.
third-news.com
January 6, 2026 at 9:14 PM
Investors Urged to Act Now in Telix Pharmaceuticals Securities Fraud Class Action Lawsuit#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Telix_Pharmaceuticals
Investors Urged to Act Now in Telix Pharmaceuticals Securities Fraud Class Action Lawsuit
Rosen Law Firm alerts investors in Telix Pharmaceuticals Ltd. about a critical lead plaintiff deadline for a securities fraud lawsuit.
third-news.com
January 6, 2026 at 8:55 PM
Key Timeline for Telix Pharmaceuticals Shareholders Regarding Legal Rights and Class Action Participation#USA#New_York#Gross_Law_Firm#Telix_Pharmaceuticals#TLX
Key Timeline for Telix Pharmaceuticals Shareholders Regarding Legal Rights and Class Action Participation
Telix Pharmaceuticals investors are urged to contact The Gross Law Firm before January 9, 2026, to explore their rights and options for recovery.
third-news.com
January 5, 2026 at 2:09 PM
Critical Deadline Approaching: Telix Pharmaceuticals Investors Urged to Join Class Action Suit#None#Telix_Pharmaceuticals#FDA_CRL#SEC_Subpoena
Critical Deadline Approaching: Telix Pharmaceuticals Investors Urged to Join Class Action Suit
Investors in Telix Pharmaceuticals Ltd. are reminded of the approaching January 9 deadline to join a class action lawsuit over SEC subpoenas and FDA setbacks on drug manufacturing.
third-news.com
January 3, 2026 at 2:07 PM
Investors Urged to Join TLX Class Action Suit by January 9 Amid Regulatory Setbacks#None#Telix_Pharmaceuticals#FDA_CRL#SEC_Subpoena
Investors Urged to Join TLX Class Action Suit by January 9 Amid Regulatory Setbacks
Hagens Berman urges Telix Pharmaceuticals investors to act by January 9 in a class action lawsuit following significant regulatory issues, causing a stock drop.
third-news.com
January 1, 2026 at 2:08 PM
Investors of Telix Pharmaceuticals: Important Deadline Approaches for Securities Fraud Lawsuit Participation#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Telix_Pharmaceuticals
Investors of Telix Pharmaceuticals: Important Deadline Approaches for Securities Fraud Lawsuit Participation
Telix Pharmaceuticals Ltd. investors have a crucial deadline approaching for a securities fraud lawsuit. Learn about your rights and steps to take.
third-news.com
January 1, 2026 at 3:04 AM
Hagens Berman Urges Telix Investors to Take Action Amid Class Action Deadline#None#Telix_Pharmaceuticals#Hagens_Berman#TLX
Hagens Berman Urges Telix Investors to Take Action Amid Class Action Deadline
Investors in Telix Pharmaceuticals are urged by Hagens Berman to act by January 9 regarding a class action lawsuit tied to SEC subpoenas and FDA concerns.
third-news.com
December 30, 2025 at 2:41 PM
Class Action Lawsuit Against Telix Pharmaceuticals: Important Information for Shareholders#United_States#New_York#Gross_Law_Firm#Telix_Pharmaceuticals#TLX
Class Action Lawsuit Against Telix Pharmaceuticals: Important Information for Shareholders
The Gross Law Firm announces a class action lawsuit against Telix Pharmaceuticals Ltd. Shareholders must act by January 9, 2026, to join.
third-news.com
December 29, 2025 at 2:22 PM
Hagens Berman Urges Timely Action for Telix Investors Facing Stock Plunge Due to Regulatory Setbacks#None#Telix_Pharmaceuticals#Hagens_Berman#SEC_Subpoena
Hagens Berman Urges Timely Action for Telix Investors Facing Stock Plunge Due to Regulatory Setbacks
Hagens Berman calls on Telix Pharmaceuticals investors to act before Jan. 9, following a stock plunge triggered by SEC probes and FDA concerns.
third-news.com
December 27, 2025 at 8:59 PM
Investors Urged to Act on Telix Pharmaceuticals Securities Fraud Lawsuit filed by The Rosen Law Firm#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Telix_Pharmaceuticals
Investors Urged to Act on Telix Pharmaceuticals Securities Fraud Lawsuit filed by The Rosen Law Firm
The Rosen Law Firm is reminding investors in Telix Pharmaceuticals that they may join a securities fraud lawsuit. Act by January 9, 2026.
third-news.com
December 26, 2025 at 8:04 PM
Hagens Berman Calls for Telix Investors to Step Up Before Class Action Deadline on Manufacturing Issues#USA#San_Francisco#Telix_Pharmaceuticals#Hagens_Berman#TLX_action
Hagens Berman Calls for Telix Investors to Step Up Before Class Action Deadline on Manufacturing Issues
Hagens Berman urges Telix Pharmaceuticals investors to take action by January 9, 2026, amidst SEC subpoenas and FDA setbacks.
third-news.com
December 24, 2025 at 8:04 PM